Diabetes mellitus and peripheral vascular disease: Is aspirin effective in preventing vascular events?

Diabetologia

Volumn 39, Issue 11, 1996, Pages 1402-1404

  Cimminiello, C ^a   Milani, M ^b,c  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b Falqui Prodotti Farmaceutici SpA   (Italy)

^c Sandoz PF   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

DIABETES MELLITUS; DIABETIC ANGIOPATHY; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ASPIRIN; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME;

EID: 0029908902     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050590     Document Type: Short Survey

References (26)

1. Reunanen A, Takkunen A. Aromaa A (1982) Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 211: 249-259
2. WHO Expert Committee on Diabetes Mellitus (1980) Second report. World Health Organisation technical report series 646 Geneva
3. Hughson WG, Mann JI, Tibbs DJ, Woods HF, Walton I (1978) Intermittent claudication: factors determining outcome. BMJ 1: 1377-1379
4. Dormandy J, Murray G (1991) The fate of the claudicant. A prospective study of 1968 claudicants. Eur J Vasc Surg 5: 131-133
5. Coffman JD (1986) Intermittent claudication. Not so benign. Am Heart J 112: 1127-1128
6. Clagett GP, Genton E, Salzman EW (1989) Antithrombotic therapy in peripheral vascular disease. Chest 95: 128S-139S
7. Kannel WB, Skinner JJ, Schwartz MJ, Shurtleff D (1970) Intermittent claudication. Incidence in the Framingham Study. Circulation 41: 875-883
8. Criqui MH, Langer RD, Fronek A et al. (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326: 381-386
9. Prevention of Atherosclerosis Complications with Ketanserin Trial Group (1988) Prevention of atherosclerotic complications: a controlled trial with Ketanserin. BMJ 298: 424-430
10. Antiplatelet Trialists' Collaboration (1988) Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 296: 320-333
11. Antiplatelet Trialisls' Collaboration (1994) Collaborative overview of randomized trials of antiplatelet therapy part I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308: 81-106
12. Chan A, Beach KW, Martin DC, Straudness DE (1983) Carotid artery disease in NIDDM diabetes. Diabetes Care 6: 562-569
13. Wood AJ (1995) Prevention and treatment of the complications of diabetes mellitus. New Engl J Med 332: 1210-1217
14. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano R (1987) Diabetes and the risk of stroke: the Honolulu Heart Program. JAMA 257: 949-952
15. Garcia ML, McNamara PM, Gordon T, Kannel WB (1974) Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23: 105-111
16. Jorgensen H, Nakayama H, Raaschou H, Olsen T (1994) Stroke in patients with diabetes: the Copenhagen stroke study. Stroke 25: 1977-1984
17. Davi G, Catalano I, Averna M (1990) Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322: 1769-1774
18. ETDRS Investigators (1992) Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 268: 1292-1300
19. The DAMAD Study Group (1989) Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy: a multi-center randomized controlled clinical trial. Diabetes 38: 491-498
20. Sivenius J, Laakso M, Riekkeinen P, Smets P, Lowenthal A (1992) European Stroke Prevention Study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke. Stroke 23: 851-854
21. Grotta JC, Norris JW, Kamm B (1990) Prevention of stroke with ticlopidine: who benefits most? Neurology 45: 411-415
22. ISIS-2 Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet ii: 349-360
23. Cotè R, Battista R, Abrahamowicz M, Langlois Y, Bourque F, Mackey A, and the Asymptomatic Cervical Bruit Study Group (1995) Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. Ann Intern Med 123: 649-655
24. Colwell JA, Bingham SF, Abraira C, Anderson JW, Comstock JP, Kwann HC (1986) Veterans Administration cooperative study group on antiplatelet agents in diabetic patients after amputation for gangrene. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates Diabetes Care 9: 140-148
25. Faulkner G, Prichard P, Somerville K, Langman MJS (1995) Aspirin and bleeding peptic ulcers in the elderly. BMJ 297: 1311-1313
26. Patrono C (1994) Aspirin as an antiplatelet drug. N Engl J Med 330: 1287-1294